,,ii  #aaith ,,congress  #b;d ,session  
,s4 #ebcg  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,august #d1    
#bjbf,ms4 ,hassan 7for herself and ,mr4 
,marshall7 introduced the following     
bill2 which was read twice and referred 
to the ,committee on ,health1           
,education1 ,labor1 and ,pensions  ,a   
,,bill  ,to require the ,director of the
 ,national ,institute of ,allergy and   
,infectious ,diseases to award a        
competitive grant for the ,antibiotic   
,resistance ,leadership ,group for the  
purpose of facilitating a clinical      
research network on antibiotic          
resistance1 and for other purposes4  #a4
 ,short title ,this ,act may be cited as
 the ,stop ,superbugs ,act4  #b4        
,funding for antibiotic resistance      
clinical research  7a7 ,in general ,the 
,director of the ,national ,institute of
 ,allergy and ,infectious ,diseases     
shall award a competitive grant for the 
,antibiotic ,resistance ,leadership     
,group for the purpose of facilitating a

 clinical research network on antibiotic
 resistance1 which shall include focuses
 on-- 7#a7 supporting rapid recruitment 
of clinical trial participants2  7#b7   
conducting clinical trial recruitment   
outreach in community settings2  7#c7   
supporting the pairing of diagnostic and
 pharmaceutical innovations during      
clinical trials2 and  7#d7 developing   
patient-reported outcomes in clinical   
studies4  7b7 ,authorization of         
appropriations ,there is authorized to  
be appropriated to the ,director of the 
,national ,institute of ,allergy and    
,infectious ,diseases such sums as may  
be necessary to carry out subsection    
7a74